Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial
Most Cited Paper
in Bacteriophages and microbial interactions
18 Months Post-Publication
Class of 2026
“Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/bacteriophages-and-microbial-interactions/2026/
Topics
LBP-EC01 · CRISPR-Cas3 · Phage cocktails · uncomplicated urinary tract infections · Escherichia coli · ELIMINATE trial · phase 2 trial · pharmacokinetics · pharmacodynamics · Engineered phages · Phage therapy · Antimicrobial resistance · bacteriophage safety · UTI treatment
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Bacteriophages and microbial interactions Papers, Class of 2026. https://pri.pepkio.com/top-papers/bacteriophages-and-microbial-interactions/2026. Accessed 2026-07-17. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459